HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Li Zhu Selected Research

Amifostine (Ethyol)

1/2016The effect of amifostine on differentiation of the human megakaryoblastic Dami cell line.
1/2011Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura.
12/2009[Mechanism and problem of amifostine in treating myelodysplastic syndromes].
7/2009[Application of bioinformatics analysis to optimize amifostine combination therapeutic regimen of myelodysplastic syndrome].
2/2008[Therapy of 17 cases of idiopathic thrombocytopenia purpura by amifostine].
10/2007[Curative efficacy of fludarabine combined with rituximab and amifostine on aged patient with B-chronic lymphocytic leukemia].
2/2007[Amifostine used in the treatment of patients with myelodysplastic syndrome].
4/2006[Early effect of amifostine in treating aged patients with idiopathic thrombocytopenia purpura].
6/2005[Short-term curative effect of amifostine combined with rhEPO on aged patients wilh myelodysplastic syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Li Zhu Research Topics

Disease

8Neoplasms (Cancer)
01/2018 - 10/2007
7Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
06/2018 - 04/2006
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016 - 12/2004
5Leukemia
01/2016 - 12/2004
5Infections
02/2015 - 12/2003
5Thrombocytopenia (Thrombopenia)
04/2014 - 04/2006
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2015 - 10/2007
4Purpura
01/2011 - 04/2006
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2021 - 04/2012
3Lymphoma (Lymphomas)
02/2017 - 10/2007
3Fever (Fevers)
02/2015 - 10/2007
3Edema (Dropsy)
04/2014 - 08/2010
2Neutropenia
08/2021 - 04/2014
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2014 - 12/2012
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2014 - 02/2013
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2013 - 01/2011
2Pleural Effusion (Pleural Effusions)
12/2012 - 08/2010
1Cardiovascular Diseases (Cardiovascular Disease)
08/2021
1Atrioventricular Block
08/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2020
1Thrombosis (Thrombus)
06/2018
1Hemorrhage
06/2018
1Hypoxia (Hypoxemia)
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
01/2018
1Cytopenia
01/2016
1Radiation Injuries (Radiation Sickness)
01/2016
1Polyploidy
01/2016
1Aspergillosis
02/2015
1Mycoses (Diseases, Fungus)
02/2015
1Asthenia
04/2014
1Anemia
04/2014
1Exanthema (Rash)
04/2014
1Residual Neoplasm
02/2014
1Plasmacytoma
02/2014
1Vomiting
12/2012
1Nausea
12/2012
1Dyspnea (Shortness of Breath)
12/2012
1Left Ventricular Dysfunction
12/2012
1Heart Failure
12/2012
1Cardiotoxicity
12/2012
1Multiple Organ Failure (MODS)
04/2012
1Tumor Lysis Syndrome
04/2012
1Inflammation (Inflammations)
06/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2011
1Autoimmune Diseases (Autoimmune Disease)
01/2011
1Cerebral Hemorrhage
01/2011
1Myocardial Infarction
10/2010
1Hematologic Neoplasms (Hematological Malignancy)
10/2010
1Ascites
08/2010
1Hepatomegaly
08/2010
1Splenomegaly
08/2010
1Aplastic Anemia (Anemia, Hypoplastic)
04/2010
1Hematologic Diseases (Blood Diseases)
12/2009
1Carcinoma (Carcinomatosis)
12/2009

Drug/Important Bio-Agent (IBA)

9Amifostine (Ethyol)FDA LinkGeneric
01/2016 - 06/2005
6Inosine Triphosphate (ITP)IBA
06/2018 - 04/2006
6CytokinesIBA
02/2014 - 10/2010
5Interleukin-2 (IL2)IBA
02/2014 - 10/2010
5Biological ProductsIBA
08/2013 - 04/2010
4Pharmaceutical PreparationsIBA
01/2016 - 10/2007
4Rituximab (Mabthera)FDA Link
10/2012 - 10/2007
3Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2010
3Monoclonal AntibodiesIBA
02/2014 - 10/2010
3fludarabineIBA
02/2012 - 12/2003
2Imatinib Mesylate (Gleevec)FDA Link
04/2014 - 12/2012
2Interferon-gamma (Interferon, gamma)IBA
02/2014 - 10/2010
2Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2013 - 12/2004
2AntibodiesIBA
01/2011 - 10/2008
1Liposomes (Liposome)IBA
08/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2021
1Long Noncoding RNAIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1HMGB1 Protein (HMG1)IBA
01/2020
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2018
1SuspensionsIBA
01/2018
1Therapeutic UsesIBA
02/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1Voriconazole (Vfend)FDA LinkGeneric
02/2015
1Indicators and Reagents (Reagents)IBA
06/2014
1Biomarkers (Surrogate Marker)IBA
06/2014
1InterferonsIBA
04/2014
1Immunomodulating AgentsIBA
02/2014
1DecitabineFDA Link
02/2013
1Peptides (Polypeptides)IBA
06/2012
1Hemoglobins (Hemoglobin)IBA
06/2011
1tanreqingIBA
02/2011
1Surface Antigens (Surface Antigen)IBA
01/2011
1liposomal doxorubicin (Doxil)FDA Link
01/2011
1Blood Proteins (Serum Proteins)IBA
08/2010
1Neutralizing AntibodiesIBA
10/2008

Therapy/Procedure

14Therapeutics
02/2015 - 12/2004
10Drug Therapy (Chemotherapy)
08/2021 - 10/2007
2Blood Transfusion (Blood Transfusions)
02/2014 - 06/2011
2Radiotherapy
02/2014 - 12/2009
2Aftercare (After-Treatment)
04/2012 - 06/2011
1Emergency Treatment
08/2021
1VAP-cyclo protocol
08/2021
1Hematopoietic Stem Cell Transplantation
02/2014
1Immunotherapy
02/2014
1Splenectomy
10/2008